miltefosine has been researched along with fluconazole in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 14 (73.68) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bettis, S; Brun, R; Fomovska, A; Huang, Q; Kaiser, M; Kozikowski, AP; McLeod, R; Mui, E; Pieroni, M; Stec, J; Witola, WH | 1 |
| Bloomer, WD; Kaiser, M; Papadopoulou, MV; Rosenzweig, HS; Wilkinson, SR | 1 |
| Lombardo, M; Ortalli, M; Quintavalla, A; Rosso, C; Trombini, C; Varani, S | 1 |
| Braga, SS | 1 |
| Cojean, S; Ferrié, L; Figadère, B; Le Pape, P; Loiseau, PM; Maciuk, A; Nguyen, LT; Pinet, A; Vásquez-Ocmín, P | 1 |
| Berman, J | 2 |
| Bravo, F; Cabello, AM; Gotuzzo, E; Legua, P; Martínez, DY; Ramos, C; Seas, C | 1 |
| Gupta, S; Sane, SA; Shakya, N | 1 |
| Click, J; Gee, SN; Hsu, MY; Rothschild, B; Saavedra, A; Sheth, V | 1 |
| Bocanegra, R; Kirkpatrick, WR; Najvar, LK; Patterson, TF; Sorrell, TC; Wiederhold, NP | 1 |
| Chaturvedi, AK; Lopez-Ribot, JL; Rozental, S; Vila, TV | 1 |
| Dunn, AL; Levy, RA; Reed, T; Stewart, C | 1 |
| Bairwa, G; Bakkeren, E; Caza, M; Hu, G; Kretschmer, M; Kronstad, J; Reiner, E | 1 |
| Ali, I; Babik, JM; Brondfield, MN; Cope, JR; DeMarco, T; Doernberg, SB; Hilts-Horeczko, A; Klein, L; Matanock, A; Reid, MJ; Ritter, JM; Rutishauser, RL; Tang, J | 1 |
| Aouthmany, S; Cooper, AM; Rega, PP; Shah, K | 1 |
| Nepal, S | 1 |
| Dooley, J; Fuller, R; Gramp, DV; Gramp, PE; Jones, A; Meumann, EM; O'Brien, B; Robertson, T; Robson, J; Simos, P; Tan, L | 1 |
5 review(s) available for miltefosine and fluconazole
| Article | Year |
|---|---|
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
Current treatment approaches to leishmaniasis.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Trials as Topic; Fluconazole; Humans; Leishmaniasis; Paromomycin; Pentamidine; Phosphorylcholine | 2003 |
Clinical status of agents being developed for leishmaniasis.
Topics: Aminoquinolines; Antiprotozoal Agents; Fluconazole; Humans; Imiquimod; Ketoconazole; Leishmaniasis; Paromomycin; Phosphorylcholine | 2005 |
Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine-containing regimen: Case report and review of the literature.
Topics: Acanthamoeba; Amebiasis; Amebicides; Amphotericin B; Anti-Bacterial Agents; Antilymphocyte Serum; Biopsy; Cardiomyopathies; Drugs, Investigational; Endoscopy; Female; Fluconazole; Flucytosine; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Magnetic Resonance Imaging; Metacarpal Bones; Metronidazole; Middle Aged; Phosphorylcholine; Polymerase Chain Reaction; Radiography; Sinusitis; Skin | 2017 |
Killer amoebas: Primary amoebic meningoencephalitis in a changing climate.
Topics: Amebicides; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiparasitic Agents; Azithromycin; Central Nervous System Protozoal Infections; Climate Change; Dexamethasone; Early Diagnosis; Early Medical Intervention; Fluconazole; Geography; Glucocorticoids; Humans; Hypothermia, Induced; Macrolides; Naegleria fowleri; Phosphorylcholine; Rifampin; United States; Ventriculostomy | 2019 |
14 other study(ies) available for miltefosine and fluconazole
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synthesis, biological evaluation, and structure-activity relationships of N-benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), Trypanosomes, and Leishmania.
Topics: Antimalarials; Benzamides; Imides; Leishmania donovani; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma; Trypanosoma brucei rhodesiense; Trypanosoma cruzi | 2012 |
Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents.
Topics: Amides; Apoptosis; Blood Platelets; Cells, Cultured; Chagas Disease; Flow Cytometry; Heterocyclic Compounds; Humans; Imidazoles; In Vitro Techniques; Leishmania donovani; Leishmaniasis, Visceral; Molecular Structure; Monocytes; Platelet Activation; Sulfonamides; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2014 |
Evaluation of synthetic substituted 1,2-dioxanes as novel agents against human leishmaniasis.
Topics: Animals; Chlorocebus aethiops; Dioxanes; Drug Design; Humans; Leishmania; Leishmaniasis; Parasitic Sensitivity Tests; Trypanocidal Agents; Vero Cells | 2019 |
Anti-protozoal and anti-fungal evaluation of 3,5-disubstituted 1,2-dioxolanes.
Topics: Antifungal Agents; Antiprotozoal Agents; Aspergillus; Candida; Dioxolanes; Dose-Response Relationship, Drug; Leishmania; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium; Structure-Activity Relationship | 2021 |
Successful treatment of Balamuthia mandrillaris amoebic infection with extensive neurological and cutaneous involvement.
Topics: Adult; Aged; Albendazole; Amebiasis; Amoebozoa; Antiprotozoal Agents; Brain; Child; Child, Preschool; Encephalitis; Female; Fluconazole; Histocytochemistry; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Phosphorylcholine; Radiography; Skin Diseases, Parasitic; Treatment Outcome; Young Adult | 2010 |
Antileishmanial efficacy of fluconazole and miltefosine in combination with an immunomodulator--picroliv.
Topics: Animals; Antiprotozoal Agents; Cinnamates; Cricetinae; Drug Therapy, Combination; Fluconazole; Glycosides; Hydrogen Peroxide; Immunity, Cellular; Leishmania donovani; Leishmaniasis, Visceral; Phagocytosis; Phosphorylcholine; Reactive Oxygen Species; Treatment Outcome; Vanillic Acid | 2011 |
Tender ulceronecrotic nodules in a patient with leukemia. Cutaneous acanthamebiasis.
Topics: Acanthamoeba; Amebiasis; Antiprotozoal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Necrosis; Pentamidine; Phosphorylcholine; Pyrimidines; Skin Diseases, Parasitic; Skin Ulcer; Sulfadoxine; Triazoles; Voriconazole | 2011 |
Limited activity of miltefosine in murine models of cryptococcal meningoencephalitis and disseminated cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Deoxycholic Acid; Drug Combinations; Fluconazole; Meningitis, Cryptococcal; Meningoencephalitis; Mice; Microbial Sensitivity Tests; Phosphorylcholine; Survival | 2013 |
In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis.
Topics: Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis, Oral; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Gene Expression; Mice; Microbial Sensitivity Tests; Mutation; Phosphorylcholine; Plankton; Transcription Factors; Treatment Outcome | 2015 |
Naegleria fowleri That Induces Primary Amoebic Meningoencephalitis: Rapid Diagnosis and Rare Case of Survival in a 12-Year-Old Caucasian Girl.
Topics: Amebiasis; Amphotericin B; Antiprotozoal Agents; Azithromycin; Central Nervous System Protozoal Infections; Cerebrospinal Fluid; Cerebrospinal Fluid Shunts; Child; Early Diagnosis; Female; Fluconazole; Humans; Hypothermia, Induced; Meningoencephalitis; Naegleria fowleri; Phosphorylcholine; Rifampin | 2016 |
A P4-ATPase subunit of the Cdc50 family plays a role in iron acquisition and virulence in Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Bacteriocins; Brefeldin A; Cell Division; Cell Membrane; Cryptococcosis; Cryptococcus neoformans; Curcumin; Endoplasmic Reticulum; Female; Fluconazole; Fungal Polysaccharides; Fungal Proteins; Iron; Macrophages; Mice; Mice, Inbred BALB C; P-type ATPases; Peptides, Cyclic; Phospholipid Transfer Proteins; Phosphorylcholine; Virulence; Virulence Factors | 2017 |
Case Report: An Atypical Erysipeloid Presentation of Cutaneous Leishmaniasis from the Hilly Region of Nepal.
Topics: Antifungal Agents; Antiprotozoal Agents; Fluconazole; Humans; Leishmaniasis, Cutaneous; Male; Middle Aged; Nepal; Phosphorylcholine | 2021 |
Fatal granulomatous amebic encephalitis initially presenting with a cutaneous lesion.
Topics: Aged; Amebiasis; Antiprotozoal Agents; Balamuthia mandrillaris; Biopsy; Fatal Outcome; Fluconazole; Humans; Infectious Encephalitis; Male; Skin | 2023 |